Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: Effect of drugs and smoking

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 2, 2005, Pages 121-131

  Getliffe, K M ^a   Al Dulaimi, D ^b   Martin Ruiz, C ^c   Holder, R L ^d   Von Zglinicki, T ^c   Morris, A ^a   Nwokolo, C U ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; MESSENGER RNA; RNA DIRECTED DNA POLYMERASE;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CELL SEPARATION; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFECT; ENTERITIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SMOKING; TELOMERE; ULCERATIVE COLITIS;

ADULT; AGED; ANTIMETABOLITES; AZATHIOPRINE; DNA-BINDING PROTEINS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTES; MALE; MIDDLE AGED; RNA, MESSENGER; SMOKING; TELOMERASE; TELOMERE;

EID: 13544263428     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02311.x     Document Type: Article

References (61)

1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-33.
2. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33.
3. Wong NA, Harrison DJ. Colorectal neoplasia in ulcerative colitis-recent advances. Histopathology 2001; 39: 221-34.
4. Loeb KR, Loeb LA. Genetic instability and the mutator phenotype. Studies in ulcerative colitis. Am J Pathol 1999; 154: 1621-6.
5. Judge TA, Lewis JD, Lichtenstein GR. Colonic dysplasia and cancer in inflammatory bowel disease. Gastrointest Endosc Clin N Am 2002; 12: 495-523.
6. van Hogezand RA, Eichhorn RF, Choudry A, et al. Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol Suppl 2002; 236: 48-53.
7. de Lange T. Protection of mammalian telomeres. Oncogene 2002; 21: 532-40.
8. Greider CW. Telomere length regulation. Annu Rev Biochem 1996; 65: 337-65.
9. McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000; 34: 331-58.
10. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-44.
11. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-82.
12. Wong JM, Collins K. Telomere maintenance and disease. Lancet 2003; 362: 983-8.
13. O'Sullivan JN, Bronner MP, Brentnall TA, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002; 32: 280-4.
14. Cottliar A, Fundia A, Boerr L, et al. High frequencies of telomeric associations, chromosome aberrations, and sister chromatid exchanges in ulcerative colitis. Am J Gastroenterol 2000; 95: 2301-7.
15. Heim S, Johansson B, Mertens F. Constitutional chromosome instability and cancer risk. Mutat Res 1989; 221: 39-51.
16. Bonassi S, Abbondandolo A, Camurri L, et al. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 1995; 79: 133-5.
17. Hagmar L, Bonassi S, Stromberg U, et al. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 1998; 58: 4117-21.
18. Dhillon VS, Dhillon IK. Chromosome aberrations and sister chromatid exchange studies in patients with prostate cancer: possible evidence of chromosome instability. Cancer Genet Cytogenet 1998; 100: 143-7.
19. Murty VV, Mitra AB, Luthra UK, et al. Sister chromatid exchanges in patients with precancerous and cancerous lesions of cervix uteri. Hum Genet 1986; 72: 37-42.
20. Paz-y-Mino C, Sanchez ME, Del Pozo M, et al. Telomeric association in women with breast and uterine cervix cancer. Cancer Genet Cytogenet 1997; 98: 115-8.
21. Richard F, Muleris M, Dutrillaux B. Chromosome instability in lymphocytes from patients affected by or genetically predisposed to colorectal cancer. Cancer Genet Cytogenet 1994; 73: 23-32.
22. Fundia AF, Gonzalez Cid MB, Bai J, et al. Chromosome instability in lymphocytes from patients with celiac disease. Clin Genet 1994; 45: 57-61.
23. Koetz K, Bryl E, Spickschen K, et al. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 2000; 97: 9203-8.
24. Schonland SO, Lopez C, Widmann T, et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A 2003; 100: 13471-6.
25. Honda M, Mengesha E, Albano S, et al. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol 2001; 99: 211-21.
26. Wu K, Higashi N, Hansen ER, et al. Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol 2000; 165: 4742-7.
27. Wu KD, Hansen ER. Shortened telomere length is demonstrated in T-cell subsets together with a pronounced increased telomerase activity in CD4 positive T cells from blood of patients with mycosis fungoides and parapsoriasis. Exp Dermatol 2001; 10: 329-36.
28. 8 Emerit I, Michelson AM. Chromosome instability in human and murine autoimmune disease: anticlastogenic effect of superoxide dismutase. Acta Physiol Scand Suppl 1980; 492: 59-65.
29. Kinne RW, Liehr T, Beensen V, et al. Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases. Arthritis Res 2001; 3: 319-30.
30. Tuschl H, Kovac R, Wolf A, et al. SCE frequencies in lymphocytes of systemic lupus erythematosus patients. Mutat Res 1984; 128: 167-71.
31. Enerback C, Holmqvist D, Inerot A, et al. Cytogenetic analysis of 477 psoriatics revealed an increased frequency of aberrations involving chromosome region 11q. Eur J Hum Genet 1999; 7: 339-44.
32. Nielsen OH, Vainer B, Rask-Madsen J. Review article: The treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 2001; 15: 1699-708.
33. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841-54.
34. Russel MG, Volovics A, Schoon EJ, et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 1998; 4: 182-6.
35. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene 2002; 21: 564-79.
36. Ulaner GA, Hu JF, Vu TH, et al. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 1998; 58: 4168-72.
37. Aisner DL, Wright WE, Shay JW. Telomerase regulation: not Just flipping the switch. Curr Opin Genet Dev 2002; 12: 80-5.
38. Wong JM, Kusdra L, Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 2002; 4: 731-6.
39. Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol 2002; 2: 699-706.
40. Usselmann B, Newbold M, Morris AG, et al. Deficiency of colonic telomerase in ulcerative colitis. Am J Gastroenterol 2001; 96: 1106-12.
41. Herrera E, Samper E, Martin-Caballero J, et al. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 1999; 18: 2950-60.
42. Lee HW, Blasco MA, Gottlieb GJ, et al. Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392: 569-74.
43. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; 1: 514.
44. Freshney R. Culture of Animal Cells: A Manual of Basic Technique. New York, USA: AR Liss, 1987.
45. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.
46. Martin-Ruiz C, Saretzki G, Petrie J, et al. Stochastic variation in telomere shortening rate causes heterogeneity of human fibroblast replicative life span. J Biol Chem 2004; 279: 17826-33.
47. Robertson JD, Gale RE, Wynn RF, et al. Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. Br J Haematol 2000; 109: 272-9.
48. Xiao L, Zhou H, Yan J, et al. Changes of telomere length in human nasopharyngeal carcinoma. Hua Xi Yi Ke Da Xue Xue Bao 1999; 30: 262-4.
49. Martens UM, Brass V, Sedlacek L, et al. Telomere maintenance in human B lymphocytes. Br J Haematol 2002; 119: 810-8.
50. Son NH, Murray S, Yanovski J, et al. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol 2000; 165: 1191-6.
51. Yamanishi Y, Hiyama K, Ishioka S, et al. Telomerase activity in the synovial tissues of chronic inflammatory and non-inflammatory rheumatic diseases. Int J Mol Med 1999; 4: 513-7.
52. Wu K, Volke A, Lund M, et al. Telomerase activity is spontaneously increased in lymphocytes from patients with atopic dermatitis and correlates with cellular proliferation. J Dermatol Sci 1999; 22: 24-30.
53. Fraser AG, Orchard TR, Robinson EM, et al. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 2002; 16: 1225-32.
54. Mariani E, Meneghetti A, Formentini I, et al. Different rates of telomere shortening and telomerase activity reduction in CD8 T and CD16 NK lymphocytes with ageing. Exp Gerontol 2003; 38: 653-9.
55. Mariani E, Meneghetti A, Formentini I, et al. Telomere length and telomerase activity: effect of ageing on human NK cells. Mech Ageing Dev 2003; 124: 403-8.
56. Fan XG, Huang Y, Tang FQ, et al. Telomerase activity of peripheral blood lymphocytes in patients with chronic hepatitis B. Immunol Lett 2000; 73: 7-11.
57. Liu K, Hodes RJ, Weng N. Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 2001; 166: 4826-30.
58. Liu K, Schoonmaker MM, Levine BL, et al. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci U S A 1999; 96: 5147-52.
59. Sheng WY, Chien YL, Wang TC. The dual role of protein kinase C in the regulation of telomerase activity in human lymphocytes. FEBS Lett 2003; 540: 91-5.
60. Proctor CJ, Kirkwood TB. Modelling cellular senescence as a result of telomere state. Aging Cell 2003; 2: 151-7.
61. Stewart ZA, Pietenpol JA. Cell cycle checkpoints as therapeutic targets. J Mammary Gland Biol Neoplasia 1999; 4: 389-400.